These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37030297)

  • 1. The economic burden of inflammatory bowel disease.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2023 May; 8(5):391. PubMed ID: 37030297
    [No Abstract]   [Full Text] [Related]  

  • 2. Financial Toxicity in People With Inflammatory Bowel Disease.
    Bloomfeld RS; Bickston SJ
    Inflamm Bowel Dis; 2021 Jun; 27(7):1170-1171. PubMed ID: 33146376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Estimates of Financial Hardship From Medical Bills and Cost-related Medication Nonadherence in Patients With Inflammatory Bowel Diseases in the United States.
    Nguyen NH; Khera R; Dulai PS; Boland BS; Ohno-Machado L; Sandborn WJ; Singh S
    Inflamm Bowel Dis; 2021 Jun; 27(7):1068-1078. PubMed ID: 33051681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing Cancer Financial Hardship Begins With Comprehensive Assessment of Patient Economic Burden.
    Shih YT; Lipscomb J
    J Natl Cancer Inst; 2021 Nov; 113(12):1606-1607. PubMed ID: 34698844
    [No Abstract]   [Full Text] [Related]  

  • 5. The Economic Burden of Illness.
    Weintraub WS
    JAMA Netw Open; 2023 Mar; 6(3):e232663. PubMed ID: 36912842
    [No Abstract]   [Full Text] [Related]  

  • 6. A theoretical model of financial burden after cancer diagnosis.
    Jones SM; Henrikson NB; Panattoni L; Syrjala KL; Shankaran V
    Future Oncol; 2020 Dec; 16(36):3095-3105. PubMed ID: 32976048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Economic Burden of Failing to Integrate Genetic Testing Into Health Care: The Time is Now.
    Maron JL
    Clin Ther; 2021 Nov; 43(11):1809-1810. PubMed ID: 34794832
    [No Abstract]   [Full Text] [Related]  

  • 8. Author Response: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Bebo BF
    Neurology; 2022 Nov; 99(18):819. PubMed ID: 36316125
    [No Abstract]   [Full Text] [Related]  

  • 9. Reader Response: The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Vargas WS
    Neurology; 2022 Nov; 99(18):818-819. PubMed ID: 36316124
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study.
    Yu Q; Zhu C; Feng S; Xu L; Hu S; Chen H; Chen H; Yao S; Wang X; Chen Y
    J Med Internet Res; 2021 Jan; 23(1):e20629. PubMed ID: 33399540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Disease Burden and Financial Problems Are Intertwined.
    Slomski A
    JAMA; 2022 Oct; 328(13):1288-1289. PubMed ID: 36194228
    [No Abstract]   [Full Text] [Related]  

  • 12. The Disease Burden of the Most Common Autoimmune Diseases.
    Mccain J
    Manag Care; 2016 Jul; 25(7):28-32. PubMed ID: 28121529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caregiver Burden in Adults With Inflammatory Bowel Disease.
    Shukla R; Thakur E; Bradford A; Hou JK
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):7-15. PubMed ID: 28529169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perception of disease, well-being and financial burden by patients with chronic hepatitis B: A self-reported assessment.
    Ding R; Morvil G; Goh BBG; Krishnamoorthy TL; Chia PY; Tan HK; Ekstrom VSM; Cheah CCM; Tan JYT; Teo PSE; Chang PEJ; Tan CK; Xin X; Chow WC; Kumar R
    Ann Acad Med Singap; 2022 Jun; 51(6):378-380. PubMed ID: 35786760
    [No Abstract]   [Full Text] [Related]  

  • 15. Spending Assessment and Economic Burden of COVID-19 in Mongolia, January- September, 2020.
    Byambadorj A; Amarsanaa S; Enebish O; Mandakh U; Batsaikhan O; Purevsuren U; Gantumur K; Yundendorj G; Davaakhuu N
    Asia Pac J Public Health; 2022 May; 34(4):456-458. PubMed ID: 35086346
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic burden of measles and its influencing factors in Fujian, China.
    Chen J; Jia H; Cai Z; Zhou Y; Ma S; Chen Y; Chen C; Pan W
    Hum Vaccin Immunother; 2021 Dec; 17(12):5367-5371. PubMed ID: 34714722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of illness analysis of inflammatory bowel disease.
    Pakdin M; Zarei L; Bagheri Lankarani K; Ghahramani S
    BMC Gastroenterol; 2023 Jan; 23(1):21. PubMed ID: 36658489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the excess bed days and economic burden of healthcare-associated infections in Singapore public acute-care hospitals.
    Cai Y; Venkatachalam I; Kwa AL; Tambyah PA; Hsu LY; Marimuthu K; Graves N
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1245-1248. PubMed ID: 34016198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Burden of Cost in Inflammatory Bowel Disease: A Medical Economic Perspective and the Future of Value-Based Care.
    Beard JA; Franco DL; Click BH
    Curr Gastroenterol Rep; 2020 Jan; 22(2):6. PubMed ID: 32002671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial Burden of Lymphedema Hospitalizations in the United States.
    Roberson ML; Strassle PD; Fasehun LO; Erim DO; Deune EG; Ogunleye AA
    JAMA Oncol; 2021 Apr; 7(4):630-632. PubMed ID: 33599683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.